HRS4R
Vull donar
Firma
GEMMA VIÑAS-VILARÓ
Posició
Investigador/a Consolidat - R3
Investigador/a Consolidat - R3

Projectes

Codi oficial: IDEAS246813BRUN Data inici: 01/12/2024 Data fi: 30/11/2026 Investigador/a principal: JOAN BRUNET VIDAL, GEMMA VIÑAS VILARÓ Organisme finançador: ASSOCIACIÓ ESPANYOLA CONTRA EL CÀNCER

Publicacions

Navarro-Sabaté, A, Font, R, Espinas, JA, Solà, J, Martínez-Soler, F, Gil-Gil, M, Viñas, G, Tibau, A, Borrell, M, Segui, M, Margelí, M, Servitja, S, Perez, C, Domenech, M, Nava, M, Marin, M, Gonzalez, S, Borràs, JM

Evaluating the Quality of Real-World Data on Adherence to Oral Endocrine Therapy in Breast Cancer Patients: How Real Is Real-World Data?

Cancers, 2025, 17 dx.doi.org/10.3390/cancers17020200
Pla H, Fullana B, Esteve A, Fort-Culillas R, Ferrando-Díez A, Fernández-Ortega A, Pous A, Stradella A, Villanueva-Vázquez R, Cirauqui B, Falo C, Martínez-Pérez E, Molina G, Del Barco S, Eraso A, Margelí M, Viñas G, Gil-Gil M, Petriz L, Pernas S

Comprehensive Clinical Characterization and Long-Term Follow-Up of the Institut Català d'Oncologia Breast Cancer Observational Cohort Study.

Cancers, 2025, 17 dx.doi.org/10.3390/cancers17081366
Sanvisens A, Vidal-Vila A, Puigdemont M, Viñas G, Roqué-Lloveras A, Del Barco S, Pérez-Bueno F, Trallero J, Marcos-Gragera R, Renart G

Population-based analysis of breast cancer incidence and mortality: overall and age-specific temporal trends over 40-year period in Girona, Spain.

BREAST CANCER RESEARCH AND TREATMENT, 2025, 212, 97-105 dx.doi.org/10.1007/s10549-025-07704-8
Roqué-Lloveras, A, Pérez-Bueno, F, Pozo-Ariza, X, Polonio-Alcalá, E, Ausellé-Bosch, S, Oliveras, G, Viñas, G, Puig, T

Breast Cancer Stem Cells and Immunogenicity Profile in High-Risk Early Triple-Negative Breast Cancer: A Pilot Study

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 dx.doi.org/10.3390/ijms26093960
Sabaté-Ortega, J, Ribera-Montserrat, A, del Barco, S, Roqué-Lloveras, A, Fort-Culillas, R, Carmona-García, MC, Liñan, R, Polonio-Alcalá, E, Carbó-Vilavedra, G, Ramos-Oliver, I, Bujons-Buscarons, E, Montañés-Ferrer, C, Viñas, G, Pla-Juher, H

Double trouble, managing bilateral inflammatory breast cancer: a case report

Frontiers in oncology, 2025, 15 dx.doi.org/10.3389/fonc.2025.1595513
Pla H, Felip E, Obadia V, Pernas S, Viñas G, Margelí M, Fort-Culillas R, Del Barco S, Sabaté N, Fort E, Lezcano C, Cirauqui B, Quiroga V, Stradella A, Gil Gil M, Esteve A, Recalde S

Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort

Clinical & Translational Oncology, 2024, 26, 1748-1758 dx.doi.org/10.1007/s12094-024-03399-3
Quintela-Fandino M, Bermejo B, Zamora E, Moreno F, García-Saenz JÁ, Pernas S, Martínez-Jañez N, Jiménez D, Adrover E, de Andrés R, Mourón S, Bueno MJ, Manso L, Viñas G, Alba E, Llombart-Cussac A, Cortés J, Tebar C, Roe DJ, Grant A, Watson A, Colomer R, Mouneimne G

High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast Cancer.

CLINICAL CANCER RESEARCH, 2024, 30, 5094-5104 dx.doi.org/10.1158/1078-0432.CCR-24-1518
Teruel I, Castellà E, Recalde S, Viñas G, Petit A, Trigueros M, Martínez-Balibrea E, Felip E, Bergamino M, Bernat-Peguera A, Cirauqui B, Quiroga V, Ferrando-Díez A, Pous A, López A, Boronat L, Soler G, Recuero J, Romeo M, Guillén P, Mesía R, Ballana E, Martínez-Cardús A, Margelí M

Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 dx.doi.org/10.3390/ijms252212241
Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Font R, Marcos-Gragera R, Puigdemont M, Viñas G, Carulla M, Espinàs JA, Galceran J, Izquierdo Á, Borràs JM

Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 dx.doi.org/10.3390/ijerph20010405
Clèries R, Buxó M, Vilardell M, Ameijide A, Martínez JM, Font R, Marcos-Gragera R, Puigdemont M, Viñas G, Carulla M, Espinàs JA, Galceran J, Izquierdo Á, Borràs JM

No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph19063605

Formulari de contacte

Coneix l’IDIBGI!

menu